Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PSA elevation during prostate cryosurgery and subsequent decline.

Dan Leibovici1, Amnon Zisman, Arie Lindner

  • 1Department of Urology and Assaf-Harofeh Medical Center, Zerifin, Israel.

Urologic Oncology
|May 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimally invasive laser enucleation of the prostate (MiLEP) in a patient with prior EPA urethroplasty and an indwelling "Butterfly" prostatic retractor device: A case report.

Urology case reports·2026
Same author

Do Urologists Adhere to Antibiotic Prophylaxis Guidelines prior to Cystoscopy?

Urologia internationalis·2026
Same author

Influence of Prostate Volume on Targeted Biopsy Outcomes and PI-RADS Predictive Value for Significant Prostate Cancer.

Journal of clinical medicine·2025
Same author

Appraisal of Clinical and Anthropometric Variables as Risk Factors for Urethroplasty Complication in Primary Hypospadias.

Journal of paediatrics and child health·2025
Same author

The novel CKD-INF score for distinguishing infectious from non-infectious inflammation in patients with non-dialysis chronic kidney disease.

Scientific reports·2025
Same author

The introduction of a mid-urethral stent for hypospadias surgery in toilet-trained children.

Pediatric surgery international·2024
Same journal

Does size matter? A national analysis of patterns of adjuvant immunotherapy receipt and tumor size-dependent survival in pT3N0M0 clear cell renal cell carcinoma.

Urologic oncology·2026
Same journal

Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesions.

Urologic oncology·2026
Same journal

Testis-sparing surgery for small testicular masses: Functional and oncological outcomes.

Urologic oncology·2026
Same journal

Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes.

Urologic oncology·2026
Same journal

Featured SUO Fellow: Soum Lokeshwar, MD MBA.

Urologic oncology·2026
Same journal

Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models.

Urologic oncology·2026
See all related articles

Prostate cryosurgery causes a sharp rise in prostate-specific antigen (PSA) levels, followed by a slower decline than anticipated based on its half-life. This impacts monitoring post-treatment.

Area of Science:

  • Oncology
  • Urology
  • Biochemistry

Background:

  • Prostate cryosurgery is a treatment for prostate cancer.
  • Prostate-specific antigen (PSA) is a biomarker used in prostate cancer management.
  • Understanding PSA dynamics post-cryosurgery is crucial for treatment evaluation.

Purpose of the Study:

  • To evaluate the immediate impact of prostate cryosurgery on PSA levels.
  • To analyze the subsequent decline of PSA after cryosurgery.
  • To compare observed PSA decline with expected levels based on serum half-life.

Main Methods:

  • Measured PSA in 14 prostate cancer patients before and after cryosurgery.
  • Collected blood samples at multiple time points: immediately pre/post-op, 1, 2, 4, 6 weeks, and 3 months.

Related Experiment Videos

  • Calculated confidence intervals for PSA elevation and compared observed vs. expected PSA decline using Student t-test.

    • Main Results:

    • Average PSA increased from 9.23 ng/mL preoperatively to a maximum of 155 ng/mL postoperatively.
    • 10 out of 14 patients achieved a nadir PSA ≤ 0.5 ng/mL.
    • Observed PSA decline was significantly slower than expected (P < 0.05 at 2, 4, and 6 weeks).

    Conclusions:

    • Prostate cryosurgery leads to a substantial, immediate increase in PSA.
    • The decline of PSA following cryosurgery is slower than predicted by its standard half-life.
    • These findings highlight the need for adjusted PSA monitoring protocols after cryosurgery.